|
Cryptome DVDs are offered by Cryptome. Donate $25 for two DVDs of the Cryptome 12-years collection of 46,000 files from June 1996 to June 2008 (~6.7 GB). Click Paypal or mail check/MO made out to John Young, 251 West 89th Street, New York, NY 10024. The collection includes all files of cryptome.org, jya.com, cartome.org, eyeball-series.org and iraq-kill-maim.org, and 23,000 pages of counter-intelligence dossiers declassified by the US Army Information and Security Command, dating from 1945 to 1985.The DVDs will be sent anywhere worldwide without extra cost. |
20 June 2008
[Federal Register: June 20, 2008 (Volume 73, Number 120)]
[Notices]
[Page 35145-35146]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20jn08-67]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Intent To Prepare an Environmental Impact Statement for
the Transport of Laboratory Personnel Exposed to Infectious Agents From
Fort Detrick, Frederick, MD to the National Institutes of Health
Clinical Center, Bethesda, MD
SUMMARY: In accordance with the National Environmental Policy Act, 42
U.S.C. 4321-4347, the NIH is issuing this notice to advise the public
that an environmental impact statement will be prepared for the
transport of laboratory personnel exposed to infectious agents from
Fort Detrick, Frederick, Maryland to the National Institutes of Health
Clinical Center, Bethesda, Maryland.
FOR FURTHER INFORMATION CONTACT: Valerie Nottingham, Chief,
Environmental Quality Branch, Division of Environmental Protection,
Office of Research Facilities, NIH, B13/2S11, 9000 Rockville Pike,
Bethesda, Maryland 20892, telephone 301-496-7775; fax 301-480-8056; or
e-mail nihnepa@mail.nih.gov.
SUPPLEMENTARY INFORMATION: Fort Detrick is a U.S. Army Medical Command
installation located in Frederick, Maryland, USA. Its 1,200 acres
support a multi-governmental community that conducts biomedical
research and development, medical material management, global medical
communications and the study of foreign plant pathogens. It is home to
the U.S. Army Medical Research and Materiel Command (USAMRMC), with its
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID),
as well as to the National Cancer Institute-Frederick (NCI-Frederick).
It is the home of the National Interagency Biodefense Campus.
The National Institute of Allergy and Infectious Diseases (NIAID),
a component of NIH, will be the occupant
[[Page 35146]]
of an Integrated Research Facility (IRF) currently being built at Fort
Detrick as part of the National Interagency Biodefense Campus. The IRF
will contain bio-safety level -2, -3, and -4 laboratory and animal
research facilities for conducting biodefense and emerging infectious
disease research. This laboratory will allow NIH to address a critical
national shortage in bio-safety level-4 (BSL-4) capability.
The Clinical Center at the National Institutes of Health (NIH) in
Bethesda, Maryland, is the nation's largest hospital devoted entirely
to clinical research. It is a national resource that makes it possible
to rapidly translate scientific observations and laboratory discoveries
into new approaches for diagnosing, treating, and preventing disease.
Approximately 1,500 studies are in progress at the NIH Clinical Center.
Most are Phase I and Phase II clinical trials.
More than 350,000 patients, from all 50 states and throughout the
world, have participated in clinical research at the Clinical Center
since it opened in 1953. The Clinical Center promotes translational
research--that is, the transference of scientific laboratory research
into applications that benefit patient health and medical care. The
``bench-to-bedside'' approach adopted in 1953 locates patient care
units in close proximity to cutting-edge laboratories doing related
research. This facilitates interaction and collaboration among
clinicians and researchers. Most important, patients and families in
the Clinical Center benefit from the cutting-edge technologies and
research and the compassionate care that are the signature of the NIH.
The Mark O. Hatfield Clinical Research Center (CRC) was opened in
2005. The facility houses inpatient units, day hospitals and research
labs and connects to the original Warren Grant Magnuson Clinical
Center. Together, the Magnuson and Hatfield buildings form the NIH
Clinical Center. They serve the dual role of providing humane and
healing patient care and the environment clinical researchers need to
advance clinical science. The 870,000-square-foot Hatfield building has
242 inpatient beds and 90 day-hospital stations. This arrangement can
be easily adapted to allow more inpatient beds and fewer day-hospital
stations, or vice versa, because the new facility's design is highly
flexible. The facility has unique ventilation systems that are designed
to minimize the spread of infectious disease within the facility and
includes isolation rooms equipped with special filtering and
containment features.
The proposed action is to transport laboratory personnel in the
event of potential exposure to infectious agents from the Fort Detrick
Campus to the NIH Clinical Center for monitoring, evaluation, and if
necessary, treatment.The CRC is well-equipped to deal with such
scenarios, unlikely as they are.
In accordance with 40 CFR 1500-1508 and DHHS environmental
procedures, NIH will prepare an Environmental Impact Statement (EIS)
for the proposed transport of laboratory personnel exposed to
infectious agents from the Fort Detrick Campus to the NIH Clinical
Center for monitoring, evaluation, and if necessary, treatment.
Among the items the EIS will examine are the implications of the
proposed action on human health, traffic and transportation, and other
public services. To ensure that the public is afforded the greatest
opportunity to participate in the planning and environmental review
process, NIH is inviting oral and written comments on the proposed
action and related environmental issues.
The NIH will be sponsoring two public Scoping Meetings to provide
individuals an opportunity to share their ideas on the proposed action,
including recommended alternatives and environmental issues the EIS
should consider. The first meeting is planned for 6:30 p.m. on July 8,
2008 at the C. Burr Artz Library, 110 East Patrick Street, Frederick,
Maryland 21701. The second meeting is planned for 7 p.m. on July 10,
2008 at the Bethesda-Chevy Chase Service Center, 4805 Edgemoor Lane,
Bethesda, Maryland 20814. All interested parties are encouraged to
attend. NIH has established a 45-day public comment period for the
scoping process. Scoping comments must be postmarked no later than
August 8, 2008 to ensure they are considered. All comments and
questions on the EIS should be directed to Valerie Nottingham at the
address listed above, telephone 301-496-7775; fax 301-480-8056; or e-
mail nihnepa@mail.nih.gov.
Dated: June 13, 2008.
Daniel Wheeland,
Director, Office of Research Facilities Development and Operations,
National Institutes of Health.
[FR Doc. E8-14033 Filed 6-19-08; 8:45 am]
BILLING CODE 4140-01-P